Russell Investments Group’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-206,845
| Closed | -$4.17M | – | 3159 |
|
|
2021
Q3 | $4.17M | Buy |
206,845
+28,079
| +16% | +$566K | 0.01% | 1352 |
|
|
2021
Q2 | $6.67M | Buy |
178,766
+96,476
| +117% | +$3.6M | 0.01% | 1164 |
|
|
2021
Q1 | $2.1M | Buy |
82,290
+16,698
| +25% | +$427K | ﹤0.01% | 1847 |
|
|
2020
Q4 | $1.44M | Sell |
65,592
-50,810
| -44% | -$1.12M | ﹤0.01% | 1927 |
|
|
2020
Q3 | $2.09M | Buy |
116,402
+31,977
| +38% | +$574K | ﹤0.01% | 1656 |
|
|
2020
Q2 | $2.14M | Buy |
84,425
+80,825
| +2,245% | +$2.05M | ﹤0.01% | 1588 |
|
|
2020
Q1 | $66K | Sell |
3,600
-25,969
| -88% | -$476K | ﹤0.01% | 2828 |
|
|
2019
Q4 | $651K | Buy |
+29,569
| New | +$651K | ﹤0.01% | 2299 |
|